Press "Enter" to skip to content

New patent for G1 Therap drug COSELA

0
Copyright © DrugPatentWatch. Originally published at New patent for G1 Therap drug COSELA

Annual Drug Patent Expirations for COSELA
Annual Drug Patent Expirations for COSELA

Cosela is a drug marketed by G1 Therap and is included in one NDA. There are eight patents protecting this drug.

This drug has ninety-six patent family members in twenty-five countries.

The generic ingredient in COSELA is trilaciclib dihydrochloride. Additional details are available on the trilaciclib dihydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for G1 Therap drug COSELA
Online Certificate Course

Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

  • When will key drug patents expire?
  • How can I find, evaluate, and plan for generic market entry opportunities?
  • How can I find proprietary out-of-court settlements and deal terms?
DrugPatentWatch - Make Better Decisions